MAY 30, 2014 10:30 AM PDT

Are we able to amplify single bacterial/viral/fungal genome equivalent?

Speaker
  • Head of Molecular Microbiology Unit- Molecular Biology, Jewish General Hospital - McGill University

Abstract

There is growing pressure to implement new generation sequencing platform in hospital emergency rooms. The utility would be obvious: identifying unknown pathogens form cerebrospinal fluid/plasma/body fluids and guiding next step in therapy. What is exactly preventing us in taking this step, if we know that billions of dollars is/was spent on revealing cancer-relevant sequence-signatures using the same technology? And one vanishes from cancer much slower comparing to 24-48h time-window of life under unrelieved life-threatening infection. What went wrong in cashing in technological advance?


Show Resources
You May Also Like
SEP 10, 2020 9:00 AM PDT
C.E. CREDITS
SEP 10, 2020 9:00 AM PDT
Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
NOV 18, 2020 8:00 AM PST
C.E. CREDITS
NOV 18, 2020 8:00 AM PST
DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
NOV 16, 2020 8:00 AM PST
C.E. CREDITS
NOV 16, 2020 8:00 AM PST
Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
OCT 29, 2020 6:00 AM PDT
C.E. CREDITS
OCT 29, 2020 6:00 AM PDT
Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
SEP 03, 2020 9:00 AM PDT
C.E. CREDITS
SEP 03, 2020 9:00 AM PDT
DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
DEC 03, 2020 4:30 PM PST
C.E. CREDITS
DEC 03, 2020 4:30 PM PST
This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
MAY 30, 2014 10:30 AM PDT

Are we able to amplify single bacterial/viral/fungal genome equivalent?


No demographic data is available yet for this event.


Show Resources
Loading Comments...
Show Resources